Rega LR, Polishchuk E, Montefusco S, Napolitano G, Tozzi G, Zhang J, Bellomo F, Taranta A, Pastore A, Polishchuk R, Piemonte F, Medina DL, Catz SD, Ballabio A, Emma F (2016) Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells
Through appetite suppression and delayed gastric emptying, patients experience sustained weight reduction, improved metabolic markers, and enhanced quality of life, with many healthcare providers finding it particularly beneficial for long-term obesity management
Photo by Innerbody Research The call itself should be brief no more than ten minutes, but probably more like two
Timelines vary
Retatrutide peptide is primarily being studied for the treatment of obesity and metabolic disorders